Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 5Gastrointestinal 5Myeloid 4Other hematologic neoplasm 2Thoracic 1NET 1Lymphoid 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 6863Lung Neoplasms 5097Small Cell Lung Carcinoma 1164Breast Neoplasms 855Neoplasms 763Colorectal Neoplasms 666Melanoma 566Ovarian Neoplasms 506Neoplasm Metastasis 480Pancreatic Neoplasms 472Stomach Neoplasms 396Adenocarcinoma of Lung 396Prostatic Neoplasms 369Head and Neck Neoplasms 367Carcinoma, Renal Cell 350Esophageal Neoplasms 337Squamous Cell Carcinoma of Head and Neck 324Mesothelioma, Malignant 324Colonic Neoplasms 293Mesothelioma 289Urinary Bladder Neoplasms 262Brain Neoplasms 253Uterine Cervical Neoplasms 242Triple Negative Breast Neoplasms 221Sarcoma 197Endometrial Neoplasms 196Carcinoma, Hepatocellular 186NSCLC 167Pleural Effusion, Malignant 160Kidney Neoplasms 160

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Piebaldism × Thoracic × Clear all
NCT06805825 2025-09-23

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

Novelty Nobility, Inc.

Phase 1 Recruiting
67 enrolled
DermatologicEndocrineGastrointestinalGenitourinaryNETSarcomaThoracic

Uveal Melanoma, Carcinoma, Renal Cell, Carcinoma, Adenoid Cystic, Piebaldism, Neuroendocrine Tumors, Gastrointestinal Stromal Tumors, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡